↓ Skip to main content

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment

Overview of attention for article published in Annals of Surgical Oncology, February 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
31 Mendeley
connotea
1 Connotea
Title
Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
Published in
Annals of Surgical Oncology, February 2011
DOI 10.1245/s10434-011-1608-4
Pubmed ID
Authors

Lena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, Thilo Sprenger, Peter Jo, Kia Homayounfar, Hendrik A. Wolff, Hilka Rothe, Peter Middel, Heinz Becker, Michael B. Ghadimi, Tim Beissbarth, Torsten Liersch

Abstract

For years, 5-fluorouracil (5-FU) has been the backbone of radiochemotherapy (RCT) of locally advanced rectal cancer. Its main target, thymidylate synthase (TS), is speculated to be an important biomarker for response prediction and long-term prognosis. In this study, we analyzed TS expression in the rectal cancer tissue of 208 patients to evaluate its predictive/prognostic potential.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Ukraine 1 3%
Hong Kong 1 3%
Unknown 28 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 29%
Student > Ph. D. Student 7 23%
Student > Master 6 19%
Student > Doctoral Student 3 10%
Other 3 10%
Other 3 10%
Readers by discipline Count As %
Medicine and Dentistry 16 52%
Agricultural and Biological Sciences 4 13%
Biochemistry, Genetics and Molecular Biology 3 10%
Unspecified 3 10%
Nursing and Health Professions 2 6%
Other 3 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2011.
All research outputs
#4,200,941
of 5,036,908 outputs
Outputs from Annals of Surgical Oncology
#1,063
of 1,376 outputs
Outputs of similar age
#55,578
of 65,158 outputs
Outputs of similar age from Annals of Surgical Oncology
#36
of 47 outputs
Altmetric has tracked 5,036,908 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,376 research outputs from this source. They receive a mean Attention Score of 2.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,158 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.